Mutations identified in the human multidrug resistance P-glycoprotein 3 (ABCB4) gene in patients with primary hepatolithiasis

被引:20
|
作者
Kano, M
Shoda, J
Sumazaki, R
Oda, K
Nimura, Y
Tanaka, N
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Gastroenterol, Tsukuba, Ibaraki 3058575, Japan
[2] Univ Tsukuba, Inst Clin Med, Dept Pediat, Tsukuba, Ibaraki 3058575, Japan
[3] Nagoya Univ, Sch Med, Dept Surg 1, Nagoya, Aichi 4668550, Japan
关键词
primary hepatolithiasis; immunostaining; heterozygous mutation;
D O I
10.1016/j.hepres.2004.03.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary hepatolithiasis (HL), highly prevalent in the Far East, including Japan, is characterized clinically by chronic proliferative cholangitis with frequent recurrences. In HL patients, hepatic hyposecretion of phospholipid due to decreased multidrug resistance P-glycoprotein 3 (MDR3; now referred to as ABCB4) expression levels (Hepatology 2001;33:1194-1205) may contribute to the formation of aggressive ductular lesions through a decreased formation of mixed micelles. However, specified factors underlying the decreased expression levels of MDR3 have not been well defined. To determine whether the decreased MDR3 expression level is associated with the gene mutations, mutation analysis of cDNA of the MDR3 gene with focus on the coding region was performed using liver specimens. Heterozygous mutations were detected in only two of 16 HL patients. By sequence analysis of the gene, a 77-bp deletion at nucleotides 537-613 in exon 7 in transmembrane domain (TM) 3, which results in a frameshift at codon 179 and an early stop codon predicting a truncated protein, was found as a heterozygous mutation in two of the 16 patients. A 1-bp deletion at nucleotide 1015 in exon 10 in TM 6 was found as a heterozygous mutation in one of those two patients, and a 242-bp deletion at nucleotides 2683-2924 in exons 22-23 in TM 11 was found as a heterozygous, mutation in the same patient. No other mutations were found in the other 14 patients. In real-time polymerase chain reaction (PCR), no significant difference was found between the mRNA levels of MDR3 in the two HL patients with mutations nor in the other 14 patients without mutations. Immunostaining of MDR3 protein was found in the bile canaliculi of liver sections from the two patients with mutations. The results suggest that in primary HL the decreased transcription levels of MDR3 in the liver are not due to the mutations detected in the coding region of the gene. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 50 条
  • [1] Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoprotein
    Jinhee Park
    Hyosung Kim
    Leen Alabdalla
    Smriti Mishra
    Hassane Mchaourab
    Human Genomics, 17
  • [2] Generation and characterization of a zebrafish knockout model of abcb4, a homolog of the human multidrug efflux transporter P-glycoprotein
    Park, Jinhee
    Kim, Hyosung
    Alabdalla, Leen
    Mishra, Smriti
    Mchaourab, Hassane
    HUMAN GENOMICS, 2023, 17 (01)
  • [3] Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)
    Ronald P. J. Oude Elferink
    Coen C. Paulusma
    Pflügers Archiv - European Journal of Physiology, 2007, 453 : 601 - 610
  • [4] Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy
    Pauli-Magnus, C
    Lang, T
    Meier, Y
    Zodan-Marin, T
    Jung, D
    Breymann, C
    Zimmermann, R
    Kenngott, S
    Beuers, U
    Reichel, C
    Kerb, R
    Penger, A
    Meier, PJ
    Kullak-Ublick, GA
    PHARMACOGENETICS, 2004, 14 (02): : 91 - 102
  • [5] Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)
    Elferink, Ronald P. J. Oude
    Paulusma, Coen C.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2007, 453 (05): : 601 - 610
  • [6] ABCB4 gene mutations and primary sclerosing cholangitis
    Rosmorduc, O
    Hermelin, B
    Boelle, PY
    Poupon, RE
    Poupon, R
    Chazouilleres, O
    GASTROENTEROLOGY, 2004, 126 (04) : 1220 - 1222
  • [7] MULTIDRUG RESISTANCE GENE (P-GLYCOPROTEIN) EXPRESSION IN THE HUMAN FETUS
    VANKALKEN, CK
    GIACCONE, G
    VANDERVALK, P
    KUIPER, CM
    HADISAPUTRO, MMN
    BOSMA, SAA
    SCHEPER, RJ
    MEIJER, CJLM
    PINEDO, HM
    AMERICAN JOURNAL OF PATHOLOGY, 1992, 141 (05): : 1063 - 1072
  • [8] ABCB4 gene mutations and primary sclerosing cholangitis -: Reply
    Trauner, M
    Fickert, P
    Lammert, F
    Marschall, HU
    GASTROENTEROLOGY, 2004, 126 (04) : 1222 - 1223
  • [9] Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation
    Sun, M.
    Kingdom, J.
    Baczyk, D.
    Lye, S. J.
    Matthews, S. G.
    Gibb, W.
    PLACENTA, 2006, 27 (6-7) : 602 - 609
  • [10] Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1)
    Hitzl, M
    Schaeffeler, E
    Hocher, B
    Slowinski, T
    Halle, H
    Eichelbaum, M
    Kaufmann, P
    Fritz, P
    Fromm, MF
    Schwab, M
    PHARMACOGENETICS, 2004, 14 (05): : 309 - 318